ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 651654 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 651654; 2) Community: the network communities that were significantly associated with the response to NSC 651654; 3) Molecule: the relationships between components within communities and NSC 651654; 4) MDR: the compounds that were significantly associated with the NSC 651654.

NSC Compound Enrichment Correlation
NSC 329250 Null 0.00559873245069072 0.10538172
NSC 654893 Null 0.00559873245069072 0.63171257
NSC 702129 Null 0.00559873245069072 -0.15936513
NSC 666783 Pyrido[2,3-d]pyrimidine-2,4-diamine, 6-[[(4-methoxy- phenyl)amino]methyl]-5-methyl-, 3/5 methanol 0.00578566967432525 0.36725901
NSC 702045 2-Propenone, 1,1'-(2,5-pyridinediyl)bis[3-(3,4-dimethoxyphenyl)- 0.00578566967432525 0.64789023
NSC 174121 Methotrexate Derivative 0.00578566967432527 0.40505846
NSC 219734 1,8-Octanediamine, N,N'-di-9-acridinyl- (9CI) 0.00578566967432527 0.42154011
NSC 272346 1,7-Heptanediamine, N,N'-bis(2-methyl-7-nitro-4-quinolinyl)-, dihydrochloride 0.00578566967432527 0.63910628
NSC 608972 Null 0.00578566967432527 0.57835666
NSC 647638 1,2-Dioxin-3-acetic acid, 3,6-dihydro-6-methoxy-6-(14,16- octadecadienyl)-, methyl ester, [3.alpha.,6.alpha.,6(14E,16E)]-(+)- (9CI) 0.00578566967432527 0.28795398
Total:104  Current:22    [First] [Prev] [Next] [Last]